secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2025-06-23T23:59:59+00:00
Accession:  0000950170-25-089074
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar posts updated corporate presentation for investor meetings
------------------------------------------------------------------

- Company posted updated slide presentation on June 23, 2025 for use in meetings with investors and analysts.
- No financial results, guidance changes, or material business events were disclosed in the filing.
- Presentation covers general corporate overview; specific new content could not be extracted from the exhibit.
- LRMR trades on Nasdaq; no material updates to pipeline or financial position reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025089074/0000950170-25-089074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017025089074/lrmr-20250623.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-089074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer